Literature DB >> 27340888

Local anesthetic lidocaine delivery system: chitosan and hyaluronic acid-modified layer-by-layer lipid nanoparticles.

Laizhu Zhang1, Jianguo Wang1, Huimin Chi1, Shilei Wang2.   

Abstract

CONTEXT: Transdermal local anesthesia is one of the most applied strategies to avoid systemic adverse effects; there is an appealing need for a prolonged local anesthetic that would provide better bioavailability and longer pain relief with a single administration.
OBJECTIVE: Layer-by-layer (LBL) technique was used in this study to explore a nanosized drug delivery system for local anesthetic therapy.
MATERIALS AND METHODS: LBL-coated lidocaine-loaded nanostructured lipid nanoparticles (LBL-LA/NLCs) were prepared and characterized in terms of particle size (PS), zeta potential, drug encapsulation efficiency (EE), in vitro skin permeation and in vivo local anesthetic studies.
RESULTS: Evaluation of the in vitro skin permeation and in vivo anesthesia effect illustrated that LBL-LA/NLCs can enhance and prolong the anesthetic effect of LA. DISCUSSION AND
CONCLUSION: LBL-LA/NLCs could function as a promising drug delivery strategy for overcoming the barrier function of the skin and could deliver anesthetic through the skin with sustained release behavior for local anesthetic therapy.

Entities:  

Keywords:  Prolonged local anesthetic; chitosan; hyaluronic acid; layer-by-layer nanoparticles; lipid-based nanoparticles

Mesh:

Substances:

Year:  2016        PMID: 27340888     DOI: 10.1080/10717544.2016.1204569

Source DB:  PubMed          Journal:  Drug Deliv        ISSN: 1071-7544            Impact factor:   6.419


  8 in total

Review 1.  The history and progress of local anesthesia: multiple approaches to elongate the action.

Authors:  Masaru Tobe; Takashi Suto; Shigeru Saito
Journal:  J Anesth       Date:  2018-05-31       Impact factor: 2.078

2.  Topical anesthetic analgesic therapy using the combination of ropivacaine and dexmedetomidine: hyaluronic acid modified long-acting nanostructured lipid carriers containing a skin penetration enhancer.

Authors:  Yongjian Yang; Dahai Qiu; Yajun Liu; Lei Chao
Journal:  Drug Des Devel Ther       Date:  2019-09-18       Impact factor: 4.162

3.  Irinotecan and 5-fluorouracil-co-loaded, hyaluronic acid-modified layer-by-layer nanoparticles for targeted gastric carcinoma therapy.

Authors:  Zhuanglei Gao; Zhaoxia Li; Jieke Yan; Peilin Wang
Journal:  Drug Des Devel Ther       Date:  2017-09-05       Impact factor: 4.162

4.  Topical anesthesia therapy using lidocaine-loaded nanostructured lipid carriers: tocopheryl polyethylene glycol 1000 succinate-modified transdermal delivery system.

Authors:  Xiangju Zhao; Ying Sun; Zhaoguo Li
Journal:  Drug Des Devel Ther       Date:  2018-12-13       Impact factor: 4.162

5.  Combination anesthetic therapy: co-delivery of ropivacaine and meloxicam using transcriptional transactivator peptide modified nanostructured lipid carriers in vitro and in vivo.

Authors:  Shu Yuan; Jun Chen; Shuo Feng; Min Li; Yingui Sun; Yuzhen Liu
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.419

6.  Synthesis of nanocapsules blended polymeric hydrogel loaded with bupivacaine drug delivery system for local anesthetics and pain management.

Authors:  Wentao Deng; Yu Yan; Peipei Zhuang; Xiaoxu Liu; Ke Tian; Wenfang Huang; Cai Li
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.419

7.  Insulin-loaded PLGA microspheres for glucose-responsive release.

Authors:  Jun-Zi Wu; Gareth R Williams; He-Yu Li; Dong-Xiu Wang; Shu-De Li; Li-Min Zhu
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

8.  Dexmedetomidine and levobupivacaine co-loaded, transcriptional transactivator peptide modified nanostructured lipid carriers or lipid-polymer hybrid nanoparticles, which performed better for local anesthetic therapy?

Authors:  Min Li; Shuo Feng; Huaixin Xing; Yingui Sun
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.